BETHESDA, Md. -- The National Foundation for Infectious Diseases (NFID) today issued a new report stressing the need for increased influenza vaccination rates among Americans with diabetes. The report was issued in response to alarmingly low influenza vaccination rates among persons with diabetes, despite recommendations from the Centers for Disease Control and Prevention (CDC), the American Diabetes Association (ADA) and others.
"People with diabetes may have impaired immune systems that put them at higher risk of serious complications from influenza," said William Schaffner, MD, NFIDs vice president. "Influenza infection can interfere with blood sugar control, leading to low or high blood sugar and in some cases, even diabetic coma. Studies have shown influenza vaccination protects people with diabetes. All healthcare professionals who serve patients with diabetes need to step up their efforts to assure that every patient with diabetes is protected against influenza."
Nearly 20 of the nation's leading medical and public health groups have joined NFID's national initiative to provide healthcare professionals with practical strategies and tools to help increase low influenza immunization rates among people with diabetes. The new resources are now available via NFID's Web site, http://www.nfid.org.
Influenza is a serious and potentially deadly respiratory infection that spreads from person to person and infects up to 60 million Americans annually. The virus is responsible for more than 200,000 hospitalizations and an average of 36,000 deaths in this country each year. Influenza kills more Americans each year than all other vaccine-preventable diseases combined. It is the fifth deadliest disease in the U.S.
Today's estimates from the CDC and the ADA indicate nearly 21 million people have diabetes, with another 54 million estimated to have impaired fasting glucose (pre-diabetes). More than 50 percent of those with diabetes (or at least 10 million people) lack protection from annual influenza vaccination, despite longstanding recommendations from the CDC and ADA. In addition, over 10 percent of deaths related to influenza and pneumonia are attributable to diabetes.
Studies have proved the effectiveness of influenza vaccine in persons with diabetes. In one study, vaccination reduced hospitalization and death by 72 percent in people with diabetes 18 to 64 years of age. Another study associated vaccination with a nearly 80 percent reduction in hospital admissions in children and adults with diabetes.
In addition to vaccinating persons with diabetes, it is also important for their close contacts, such as family members, close friends and co-workers, to be vaccinated. Close contacts can easily transmit influenza to those around them if they become ill.
"People don't realize how easily influenza can pass from one person to another in social, family and work environments," said NFID medical director Susan J. Rehm, MD. "Getting an influenza vaccination every year ensures we protect ourselves and those around us, especially those more vulnerable like people with diabetes."
Source: National Foundation for Infectious Diseases
  Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.